Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
The Journal of Clinical Psychiatry|May 4, 2006
Genetics, transcriptomics, and proteomics of Alzheimer's diseaseAndreas Papassotiropoulos, Michael Fountoulakis, Travis Dunckley, et al.Plos One|May 17, 2011
β-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sitesDanielle Frost, Bessie Meechoovet, Tong Wang, et al.Scientific Reports|September 23, 2022
DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicityBangfu Zhu, Tom Parsons, Christopher Foley, et al.Molecular Neurobiology|June 27, 2019
Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD MiceR Velazquez, B Meechoovet, A Ow, et al.Frontiers in Genetics|May 13, 2021
DNA Methylation and Expression Profiles of Whole Blood in Parkinson's DiseaseAdrienne R Henderson, Qi Wang, Bessie Meechoovet, et al.Aging Cell|August 6, 2017
Dyrk1 inhibition improves Alzheimer's disease-like pathologyCaterina Branca, Darren M Shaw, Ramona Belfiore, et al.Epigenetics|March 16, 2019
DNA methylation changes associated with Parkinson's disease progression: outcomes from the first longitudinal genome-wide methylation analysis in bloodAdrienne Henderson-Smith, Kathleen M Fisch, Jianping Hua, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2008
Neuronal gene expression correlates of Parkinson's disease with dementiaChelsea Stamper, Andrew Siegel, Winnie S Liang, et al.Journal of Alzheimer'S Disease : JAD|February 19, 2016
The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's DiseaseBrittany N Dugger, Charisse M Whiteside, Chera L Maarouf, et al.Mitochondrion|August 22, 2006
Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencingKeith D Coon, Jon Valla, Szabolics Szelinger, et al.Pageof 4